16 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
Multifocal (or multiform) atrial tachycardia (MAT) is an abnormal heart rhythm, specifically a type of supraventricular
sinoatrial node (SA ... outside of the SA ... Clinical #MedStudent #EKG ... MultifocalAtrialTachycardia #ECGEducator
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
amphotericin B, 3 to 5 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
loss (>5 lb; 2.5 kg ... Presentations: • Opportunistic ... in which case opportunistic ... HIV-1 p24 core Ag
A wandering atrial pacemaker, (WAP), is an atrial arrhythmia that occurs when the natural cardiac pacemaker
sinoatrial node (SA ... pacemaker from the SA ... identifiable on ECG ... Clinical #MedStudent #EKG ... WanderingAtrialPacemaker #ECGEducator
A junctional escape beat is a delayed heartbeat originating not from the atrium but from an
impulses from the SA ... node because of SA ... function when the SA ... Clinical #MedStudent #EKG ... JunctionalEscape #ECGEducator
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
acyclovir 5 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
amphotericin B 3–4 mg/kg ... flucytosine 25 mg/kg ... flucytosine 25 mg/kg ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology